CYDY CYDY

CytoDyn (QB) Stock Price

0.335
-0.01 (-2.9%)
0.335
Volume 1,357,212
Bid Price 0.3311
Ask Price 0.337
News -
Day High 0.346

Low
0.2311

52 Week Range

High
1.30

Day Low 0.33
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -2.9% 0.335 16:08:22
Open Price Low Price High Price Close Price Prev Close
0.34 0.33 0.346 0.335 0.345
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
371 1,357,212 $ 0.335921 $ 455,916 - 0.2311 - 1.30
Last Trade Time Type Quantity Stock Price Currency
16:05:54 average 122,000 $ 0.33485 USD

Period:

Draw Mode:

CytoDyn Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 272.91M 814.64M 556.02M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
33.93M $ - - - -

more financials information »

CytoDyn (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.34510.3750.330.3513302689,697-0.0101-2.93%
1 Month0.3480.43450.31010.36716441,145,326-0.013-3.74%
3 Months0.610.630.31010.42230151,168,798-0.275-45.08%
6 Months0.3311.300.310.61572311,890,5190.0041.21%
1 Year1.121.300.23110.58919982,308,468-0.785-70.09%
3 Years0.29310.010.23112.713,727,5520.04214.33%
5 Years0.6110.010.05522.562,411,410-0.275-45.08%

CytoDyn (QB) Description

CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions.